Bioorganic and Medicinal Chemistry Letters, volume 95, pages 129471
Synthesis and anti-tumor activities in human leukemia-derived cells of polyenylpyrroles with a methyl group at the conjugated polyene terminus
Tomoya Higashi
1
,
Chihiro Yoshida
1
,
Yoshifumi Hachiro
1
,
Chihiro Nakata
2, 3
,
Azusa Takechi
3, 4
,
Takuya Yagi
2, 3
,
Kazuya MIYASHITA
3, 5
,
Nobuo Kitada
1
,
Rika Obata
6
,
Takashi Hirano
6
,
Takahiko Hara
2, 3, 4
,
Shojiro MAKI
1
Publication type: Journal Article
Publication date: 2023-10-01
scimago Q2
wos Q2
SJR: 0.508
CiteScore: 5.7
Impact factor: 2.5
ISSN: 0960894X, 14643405
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
To develop novel drugs for treating T-cell acute lymphoblastic leukemia (T-ALL) and acute myeloid leukemia (AML) which are highly malignant hematological tumors, a series of analogs having a polyenylpyrrole structure of natural compounds (rumbrin and auxarconjugatin B) were synthesized and investigated their structure-activity relationships (SAR) of in vitro anti-T-ALL and anti-AML activities. We obtained three findings: (1) introduction of a methyl group at the conjugated polyene terminus enhanced anti-T-ALL activity, (2) analogs with a 3-chloropyrrole moiety had even higher selectivity for T-ALL cells, and (3) some analogs were effective against AML-derived cells. Among the studied compounds, 3-chloro-2-(8-ethoxycarbonylnona-1,3,5,7-tetraenyl) pyrrole 4e was the most promising candidate of T-ALL- and AML-treating drug. This study provides useful structural information for designing novel drugs treating T-ALL and AML.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.